Targeted Cancer Therapy with a 2-Deoxyglucose-Based Adriamycin Complex

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works

Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells

Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813 · see citing works

Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Ganapathy, V., Thangaraju, M., & Prasad, P. (2009) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2008.09.005 · Cited by 711 · see citing works

Analysis of anticancer drugs: A review

Nussbaumer, S., Bonnabry, P., Veuthey, J., & Fleury‐Souverain, S. (2011) · Talanta · doi:10.1016/j.talanta.2011.08.034 · Cited by 570 · see citing works

Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

Gallagher, B. M., Fowler, J. S., Gutterson, N. I., MacGregor, R. R., Wan, C.-N., & Wolf, A. P. (1978) · PubMed · Cited by 557 · see citing works

2-Deoxy- d -glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo

Maschek, G., Savaraj, N., Priebe, W., Braunschweiger, P. G., Hamilton, K., Tidmarsh, G. F., Young, L. R. D., & Lampidis, T. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3294 · Cited by 452 · see citing works

Molecular physiology of sodium-glucose cotransporters.

Hediger, M. A., & Rhoads, D. B. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.993 · Cited by 417 · see citing works

Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer

Yalçın, A., Telang, S., Clem, B. F., & Chesney, J. A. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.003 · Cited by 407 · see citing works

GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis

Amann, T., Maegdefrau, U., Hartmann, A., Agaimy, A., Marienhagen, J., Weiß, T. S., Stoeltzing, O., Warnecke, C., Schölmerich, J., Oefner, P. J., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080596 · Cited by 370 · see citing works

Prodrugs for improving tumor targetability and efficiency

Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 355 · see citing works

Translating cancer research into targeted therapeutics

Bono, J. S. D., & Ashworth, A. (2010) · Nature · doi:10.1038/nature09339 · Cited by 333 · see citing works

Prodrug-based intracellular delivery of anticancer agents

Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 309 · see citing works

Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro

Kievit, F. M., Wang, F. Y., Fang, C., Mok, H., Wang, K., Silber, J. R., Ellenbogen, R. G., & Zhang, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.024 · Cited by 291 · see citing works

Improving cancer radiotherapy with 2-deoxy-d-glucose: phase I/II clinical trials on human cerebral gliomas

Mohanti, B. K., Rath, G. K., Anantha, N., Kannan, V., Das, B. S., Chandramouli, B. A., Banerjee, A. K., Das, S., Jena, A., Ravichandran, R., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)85017-6 · Cited by 283 · see citing works

Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin

Cho, H., Yoon, I., Yoon, H. Y., Koo, H., Jin, Y.-J., Ko, S.-H., Shim, J.-S., Kim, K., Kwon, I. C., & Kim, D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.064 · Cited by 266 · see citing works

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆

Pathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 265 · see citing works

2-Deoxy- d -Glucose Combined with Cisplatin Enhances Cytotoxicity via Metabolic Oxidative Stress in Human Head and Neck Cancer Cells

Simons, A. L., Ahmad, I. M., Mattson, D., Dornfeld, K. J., & Spitz, D. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3717 · Cited by 238 · see citing works

The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer

van Baardwijk, A. A. W., Dooms, C., van Suylen, R. J., Verbeken, E. K., Hochstenbag, M. M. H., Oberije, C., Rupa, D., Pastoreková, S., Stroobants, S. G., Buell, U., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.03.027 · Cited by 196 · see citing works

Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy

Raschi, E., Vasina, V. I., Ursino, M. G., Boriani, G., Martoni, A. A., & Ponti, F. D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.002 · Cited by 151 · see citing works

Direct Inhibition of the Hexose Transporter GLUT1 by Tyrosine Kinase Inhibitors

Vera, J. C., Reyes, A. M., Velásquez, F. V., Rivas, C. I., Zhang, R. H., Strobel, P., Slebe, J. C., Núñez-Alarcón, J. A., & Golde, D. W. (2000) · Biochemistry · doi:10.1021/bi001660j · Cited by 109 · see citing works

Folate-decorated maleilated pullulan–doxorubicin conjugate for active tumor-targeted drug delivery

Zhang, H., Li, F., Yi, J., Gu, C., Fan, L., Qiao, Y., Tao, Y., Cheng, C., & Wu, H. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.02.006 · Cited by 108 · see citing works

The targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model

Zhang, J., Chen, H., Xu, L. S., & Gu, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.019 · Cited by 102 · see citing works

In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells

Ogawara, K.-I., Un, K., Tanaka, K.-I., Higaki, K., & Kimura, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.008 · Cited by 101 · see citing works

Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells

Zheng, C., Xu, J., Yao, X., Xu, J., & Qiu, L. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.12.004 · Cited by 68 · see citing works

Enhanced Response of Human Head and Neck Cancer Xenograft Tumors to Cisplatin Combined With 2-Deoxy-d-Glucose Correlates With Increased 18F-FDG Uptake as Determined by PET Imaging

Simons, A. L., Fath, M. A., Mattson, D., Smith, B. J., Walsh, S. A., Graham, M. M., Hichwa, R. D., Buatti, J. M., Dornfeld, K. J., & Spitz, D. R. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.07.2343 · Cited by 64 · see citing works

Chemotherapy counteracted

Emmenegger, U., & Kerbel, R. S. (2010) · Nature · doi:10.1038/468637a · Cited by 53 · see citing works

Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung

Song, Y. S., Lee, W., Chung, J.-H., Park, S. Y., Kim, Y. K., & Kim, S. E. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.11.012 · Cited by 51 · see citing works

A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy

Shan, L., Cui, S., Du, C., Wan, S., Qian, Z., Achilefu, S., & Gu, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.025 · Cited by 49 · see citing works

Synthesis and cytotoxic properties of new fluorodeoxyglucose-coupled chlorambucil derivatives

Reux, B., Weber, V., Galmier, M., Borel, M., Madesclaire, M., Madelmont, J., Débiton, E., & Coudert, P. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.038 · Cited by 43 · see citing works

Comparison of near‐infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo

Guo, J., Du, C., Shan, L., Zhu, H., Xue, B., Qian, Z., Achilefu, S. A., & Gu, Y. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.496 · Cited by 40 · see citing works

Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management

Perrino, C., Schiattarella, G. G., Magliulo, F., Ilardi, F., Carotenuto, G., Gargiulo, G., Serino, F., Ferrone, M. L., Scudiero, F., Carbone, A., et al. (2014) · Current Vascular Pharmacology · doi:10.2174/157016111201140327163302 · Cited by 33 · see citing works

Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas

Suzuki, H., Fukuyama, R., Hasegawa, Y., Tamaki, T., Nishio, M., Nakashima, T., & Tatematsu, M. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.03.009 · Cited by 31 · see citing works

Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents

Miot-Noirault, É., Reux, B., Débiton, E., Madelmont, J., Chezal, J., Coudert, P., & Weber, V. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9371-0 · Cited by 24 · see citing works

Synthesis, characterization, and in vitro and in vivo evaluation of a novel pectin–adriamycin conjugate

Tang, X., Xie, P., Ding, Y., Chu, L., Hou, J.-P., Yang, J., Song, X. Y., & Xie, Y. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.076 · Cited by 23 · see citing works

Discovery of matrix metalloproteases selective and activated peptide–doxorubicin prodrugs as anti-tumor agents

Hu, Z., Jiang, X., Albright, C. F., Graciani, N. R., Yue, E. W., Zhang, M., Zhang, S., Brückner, R., Diamond, M. A., Dowling, R. L., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.084 · Cited by 19 · see citing works

Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs

Daumar, P., Decombat, C., Chezal, J., Débiton, E., Madesclaire, M., Coudert, P., & Galmier, M. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.04.010 · Cited by 18 · see citing works

DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin

Štěpánková, J., Studenovský, M., Malina, J., Kašpárková, J., Lišková, B., Nováková, O., Ulbrich, K., & Brabec, V. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.010 · Cited by 17 · see citing works

Gamma irradiation reduces the immunological toxicity of doxorubicin, anticancer drug

Kim, J., Sung, N., Raghavendran, H. R. B., Yoon, Y., Song, B., Choi, J.-I., Yoo, Y., Byun, M., Hwang, Y.-J., & Lee, J.-W. (2009) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2009.03.020 · Cited by 9 · see citing works

Glucose Conjugation for the Specific Targeting and Treatment of Cancer

Calvaresi, E. C., & Hergenrother, P. J. (2013) · Chemical Science · doi:10.1039/c3sc22205e · Cited by 398 · see citing works

Altered glycosylation in cancer: A promising target for biomarkers and therapeutics

Thomas, D., Ashokkumar, R., & Radhakrishnan, P. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188464 · Cited by 376 · see citing works

Iron as a central player and promising target in cancer progression

Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works

Glucose Transporters as a Target for Anticancer Therapy

Pliszka, M., & Szablewski, L. (2021) · Cancers · doi:10.3390/cancers13164184 · Cited by 208 · see citing works

Small Molecules for Active Targeting in Cancer

Kue, C. S., Kamkaew, A., Burgess, K., Kiew, L. V., Chung, L. Y., & Lee, H. B. (2016) · Medicinal Research Reviews · doi:10.1002/med.21387 · Cited by 143 · see citing works

Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds

Barbosa, A. M., & Martel, F. (2020) · Cancers · doi:10.3390/cancers12010154 · Cited by 137 · see citing works

Glycosidase activated prodrugs for targeted cancer therapy

Martin, H., Lázaro, L. R., Gunnlaugsson, T., & Scanlan, E. M. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00379a · Cited by 127 · see citing works

Developments in Carbohydrate-Based Cancer Therapeutics

Hossain, F., & Andreana, P. R. (2019) · Pharmaceuticals · doi:10.3390/ph12020084 · Cited by 120 · see citing works

Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights

Zheng, P., Li, J., & Kros, J. M. (2017) · Medicinal Research Reviews · doi:10.1002/med.21463 · Cited by 97 · see citing works

Metabolic Aspects of Anthracycline Cardiotoxicity

Russo, M., Sala, A. D., Tocchetti, C. G., Porporato, P. E., & Ghigo, A. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-00812-1 · Cited by 94 · see citing works

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies

Molinaro, C., Martoriati, A., & Cailliau, K. (2021) · Cancers · doi:10.3390/cancers13153819 · Cited by 93 · see citing works

Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells

Venturelli, L., Nappini, S., Bulfoni, M., Gianfranceschi, G., Zilio, S. D., Coceano, G., Ben, F. D., Turetta, M., Scoles, G., Vaccari, L., et al. (2016) · Scientific Reports · doi:10.1038/srep21629 · Cited by 85 · see citing works

Anticancer agents interacting with membrane glucose transporters

Granchi, C., Fortunato, S., & Minutolo, F. (2016) · MedChemComm · doi:10.1039/c6md00287k · Cited by 71 · see citing works

Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment

Fu, J., Yang, J., Seeberger, P. H., & Yin, J. (2020) · Carbohydrate Research · doi:10.1016/j.carres.2020.108195 · Cited by 73 · see citing works

Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer.

Shao, B., Li, C.-W., Lim, S., Sun, L., Lai, Y., Hou, J., Liu, C., Chang, C.-W. M., Qiu, Y., Hsu, J.-M., et al. (2018) · Europe PMC (PubMed Central) · Cited by 65 · see citing works

Quaternary Zn–Ag–In–Se Quantum Dots for Biomedical Optical Imaging of RGD-Modified Micelles

Deng, D., Qu, L., Zhang, J., Ma, Y., & Gu, Y. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am403050s · Cited by 63 · see citing works

Novel Linear Peptides with High Affinity to αvβ3 Integrin for Precise Tumor Identification

Ma, Y., Ai, G., Zhang, C., Zhao, M., Dong, X., Han, Z., Wang, Z., Zhang, M., Liu, Y., Gao, W., et al. (2017) · Theranostics · doi:10.7150/thno.18401 · Cited by 62 · see citing works

Synthesis, Binding Properties, and Differences in Cell Uptake of G‐Quadruplex Ligands Based on Carbohydrate Naphthalene Diimide Conjugates

Arévalo‐Ruiz, M., Doria, F., Belmonte‐Reche, E., Rache, A. D., Campos‐Salinas, J., Lucas, R., Falomir, E., Cardá, M., Pérez-Victoria, J. M., Mergny, J., et al. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604886 · Cited by 57 · see citing works

Galactose as Broad Ligand for Multiple Tumor Imaging and Therapy

Ma, Y., Chen, H., Su, S., Wang, T., Zhang, C., Fida, G., Cui, S., Zhao, J., & Gu, Y. (2015) · Journal of Cancer · doi:10.7150/jca.11647 · Cited by 56 · see citing works

HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy

Luo, P., Zhu, Y., Chen, M., Yan, H., Yang, B., Yang, X., & He, Q. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.034 · Cited by 52 · see citing works

Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study.

Xu, Y., Wu, T., Zhou, S., Bao, Y., Wang, Q., Fan, J., & Huang, Y. (2014) · PubMed Central · Cited by 51 · see citing works

Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators

Akam, E. A., & Tomat, E. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00332 · Cited by 48 · see citing works

Application of Mono‐ and Disaccharides in Drug Targeting and Efficacy

Yuan, S., Li, M. L., Chen, J. S., Zhou, L., & Zhou, W. (2018) · ChemMedChem · doi:10.1002/cmdc.201700762 · Cited by 46 · see citing works

Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1

Liu, R., Li, H., Gao, X., Mi, Q., Zhao, H., & Gao, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.004 · Cited by 42 · see citing works

Biomedical applications of acrylic-based nanohydrogels

Swain, S. K., & Prusty, K. (2017) · Journal of Materials Science · doi:10.1007/s10853-017-1726-x · Cited by 41 · see citing works

Cellular Internalization of Therapeutic Oligonucleotides by Peptide Amphiphile Nanofibers and Nanospheres

Mumcuoglu, D., Ekiz, M. Ş., Gunay, G., Tekinay, T., Tekinay, A. B., & Guler, M. O. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b01526 · Cited by 41 · see citing works

Novel harmine derivatives for tumor targeted therapy

Li, S., Wang, A., Gu, F., Wang, Z., Tian, C., Qian, Z., Tang, L., & Gu, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3276 · Cited by 39 · see citing works

Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo

Ma, Z., He, H., Sun, F., Xu, Y., Huang, X., Ma, Y., Zhao, H., Wang, Y., Wang, M., & Zhang, J. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2436-0 · Cited by 36 · see citing works

A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy

Pastuch-Gawołek, G., Szreder, J., Domińska, M., Pielok, M., Cichy, P., & Grymel, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030913 · Cited by 36 · see citing works

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness

Fujita, M., Imadome, K., Somasundaram, V., Kawanishi, M., Karasawa, K., & Wink, D. A. (2020) · BMC Cancer · doi:10.1186/s12885-020-07414-y · Cited by 32 · see citing works

Glycoconjugation: An approach to cancer therapeutics

Molejon, M. I., Weiz, G., Breccia, J. D., & Molejon, M. I. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i3.110 · Cited by 32 · see citing works

Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment—In Vitro, In Vivo and Clinical Trials Literature Review

Szulc, A., & Woźniak, M. (2024) · Cancers · doi:10.3390/cancers16081483 · Cited by 29 · see citing works

Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma

White, N. M. A., Newsted, D., Masui, O., Romaschin, A. D., Siu, K. W. M., & Yousef, G. M. (2013) · Tumor Biology · doi:10.1007/s13277-013-1245-6 · Cited by 29 · see citing works

L-Glucose: Another Path to Cancer Cells

Ono, K., Takigawa, S., & Yamada, K. (2020) · Cancers · doi:10.3390/cancers12040850 · Cited by 20 · see citing works

68 Ga-labeled dendrimer-entrapped gold nanoparticles for PET/CT dual-modality imaging and immunotherapy of tumors

Cai, L., Zhao, L., Liang, J., Ouyang, Z., Gao, Y., Guo, R., Song, S., Shi, X., & Cao, X. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00378c · Cited by 24 · see citing works

The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

Guo, X., Song, J., Liu, M., Ou, X., & Guo, Y. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2356831 · Cited by 24 · see citing works

Linoleic Acid–Glucosamine Hybrid for Endogenous Iron-Activated Ferroptosis Therapy in High-Grade Serous Ovarian Cancer

Chen, Y., Liao, X., Jing, P., Hu, L., Yang, Z., Yao, Y., Liao, C., & Zhang, S. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00333 · Cited by 22 · see citing works

Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects

Han, J., Gao, X., Liu, R., Yang, J., Zhang, M., Mi, Y. M., Shi, Y., & Gao, Q. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12718 · Cited by 22 · see citing works

The flavonoid quercetin: Possible solution for anthracycline-induced cardiotoxicity and multidrug resistance

Czepas, J., & Gwoździński, K. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.013 · Cited by 21 · see citing works

4,5-Diazafluorene N-glycopyranosyl hydrazones as scaffolds for potential bioactive metallo-organic compounds: Synthesis, structural study and cytotoxic activity

Jäger, S., Gude, L., & Arias, M. S. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.08.019 · Cited by 19 · see citing works

A Warburg effect targeting vector designed to increase the uptake of compounds by cancer cells demonstrates glucose and hypoxia dependent uptake

Glenister, A., Simone, M. I., & Hambley, T. W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217712 · Cited by 19 · see citing works

Glucose-installed biodegradable polymeric micelles for cancer-targeted drug delivery system: synthesis, characterization and in vitro evaluation

Theerasilp, M., Chalermpanapun, P., Sunintaboon, P., Sungkarat, W., & Nasongkla, N. (2018) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6177-7 · Cited by 18 · see citing works

Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro

Khajah, M. A., Khushaish, S., & Luqmani, Y. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272449 · Cited by 17 · see citing works

Aroylhydrazone Glycoconjugate Prochelators Exploit Glucose Transporter 1 (GLUT1) to Target Iron in Cancer Cells

Sung, Y., Kerimoğlu, B., Ooi, A., & Tomat, E. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00250 · Cited by 17 · see citing works

Advances in Gold Nanoparticles: Synthesis, Functionalization Strategies, and Theranostic Applications in Cancer

Damani, M., Jadhav, M., Joshi, R., Singh, B. P., Momin, M. M., Ningthoujam, R. S., & Khan, T. A. (2024) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2024046712 · Cited by 17 · see citing works

Blocking the Glycolytic Pathway Sensitizes Breast Cancer to Sonodynamic Therapy

Xie, L., Feng, X., Shi, Y., He, M., Wang, P., Wang, X., Mi, Z., Liu, Q., & Zhang, K. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.01.020 · Cited by 19 · see citing works

Glycoconjugation of Quinoline Derivatives Using the C-6 Position in Sugars as a Strategy for Improving the Selectivity and Cytotoxicity of Functionalized Compounds

Domińska, M., Pastuch-Gawołek, G., Skonieczna, M., Szeja, W., Domiński, A., & Kurcok, P. (2022) · Molecules · doi:10.3390/molecules27206918 · Cited by 16 · see citing works

Reversing Reactivity: Stereoselective Desulfurative 1,2- trans - O -Glycosylation of Anomeric Thiosugars with Carboxylic Acids under Copper or Cobalt Catalysis

Bennai, N., Chabrier, A., Fatthalla, M. I., Tran, C., Yen‐Pon, E., Belkadi, M., Alami, M., Grimaud, L., & Messaoudi, S. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c00766 · Cited by 15 · see citing works

Glycosylation and its research progress in endometrial cancer

Pu, C., Biyuan, Xu, K. L., & Zhao, Y. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02858-z · Cited by 15 · see citing works

Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology

Ovcharenko, D., Mukhin, D., & Ovcharenko, G. V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091237 · Cited by 14 · see citing works

Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer

Timur, S. S., Bhattarai, P. R., Gürsoy, R. N., Vural, İ., & Khaw, B. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2066-2 · Cited by 14 · see citing works

Enhancing the Therapeutic Efficacy of 2-Deoxyglucose in Breast Cancer Cells Using Cell-cycle Synchronization

Lee, S. J., Park, B.-N., Roh, J. H., An, Y., Hur, H., & Yoon, J. (2016) · Anticancer Research · doi:10.21873/anticanres.11185 · Cited by 13 · see citing works

Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells

Buchanan, M. K., Needham, C. N., Neill, N. E., White, M. C., Kelly, C. B., Mastro-Kishton, K., Chauvignè-Hines, L. M., Goodwin, T. J., McIver, A. L., Bartolotti, L. J., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01075 · Cited by 13 · see citing works

Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives

Li, H., Wang, K., Wan, Q., & Chen, Y. (2018) · Steroids · doi:10.1016/j.steroids.2018.11.018 · Cited by 12 · see citing works

A comparative study of the in vitro antitumor effect of mannose‐doxorubicin conjugates with different linkers

Cui, X., Du, K., Yuan, X., Xiao, W. F., Tao, Y., Xu, D., & Hu, H. (2021) · Drug Development Research · doi:10.1002/ddr.21896 · Cited by 11 · see citing works

Glycated nisin enhances nisin's cytotoxic effects on breast cancer cells

Mohammadi, A., Kazemipour, N., Ghorbankhani, G. A., Morovati, S., & Sadeghian, M. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-68765-1 · Cited by 11 · see citing works

Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach

Shafi, S., Khan, M. A., Ahmad, J., Rabbani, S. A., Singh, S., & Najmi, A. K. (2024) · Current Drug Targets · doi:10.2174/0113894501335877240926101134 · Cited by 10 · see citing works

Glucose targeted therapy against liver hepatocellular carcinoma: In vivo study

Mazumder, A., Assawapanumat, W., Dwivedi, A., Reabroi, S., Chairoungdua, A., & Nasongkla, N. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.036 · Cited by 10 · see citing works

Discovery of highly potent and selective 7-ethyl-10-hydroxycamptothecin-glucose conjugates as potential anti-colorectal cancer agents

Yang, C., Xia, A., Du, C., Hu, M., Gong, Y., Tian, R., Jiang, X., & Xie, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1014854 · Cited by 10 · see citing works

The Conjugates of Indolo[2,3-b]quinoline as Anti-Pancreatic Cancer Agents: Design, Synthesis, Molecular Docking and Biological Evaluations

Cybulski, M., Sidoryk, K., Zaremba-Czogalla, M., Trzaskowski, B., Kubiszewski, M., Tobiasz, J., Jaromin, A., & Michalak, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052573 · Cited by 9 · see citing works

Combined Treatment with 2-Deoxy-D-Glucose and Doxorubicin Enhances the in Vitro Efficiency of Breast Cancer Radiotherapy

Islamian, J. P., Aghaee, F., Farajollahi, A., Baradaran, B., & Fazel, M. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8431 · Cited by 9 · see citing works

Synthesis of flavonoid 2-deoxyglucosides via the Mitsunobu reaction

Han, Z., Zheng, Z., Cai, L., Zhou, D., Li, C., Sui, Q., Liu, S., & Gao, Q. (2018) · Tetrahedron Letters · doi:10.1016/j.tetlet.2018.09.008 · Cited by 9 · see citing works

Oxime Linked Doxorubicin Glycoconjugates Improve the Specific Targeting of Glioblastoma in High-Grade Glioma Therapy

Iorio, A. L., Lenci, E., Marzano, C., Bucaletti, E., Tirinnanzi, B., Casati, G., Giunti, L., Dallari, C., Credi, C., Sardi, I., et al. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00398 · Cited by 7 · see citing works

Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy

Hilali, M. E., Reux, B., Débiton, E., Leal, F., Galmier, M., Vivier, M., Chezal, J., Miot-Noirault, E., Coudert, P., & Weber, V. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.043 · Cited by 6 · see citing works

Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma

Zhang, C., Huang, S., Ding, K., Wu, H., Li, M., Li, T., Shen, Z., Tai, S., & Li, W. M. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00437 · Cited by 5 · see citing works

An in vitro cytotoxicity of glufosfamide in HepG2 cells relative to its nonconjugated counterpart

Ahmed, D. E., Rashidi, F. B., Abdelhakim, H. K., Mohamed, A. S., & Arafa, H. M. M. (2021) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-021-00080-6 · Cited by 5 · see citing works

Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors

Wang, Z., Liu, R., Zhang, X., Chang, X., Gao, M., Zhang, S., Guan, Q., Sun, J. F., Zuo, D., & Zhang, W. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116671 · Cited by 5 · see citing works

Transdermal sequential delivery of functionalized Nano-Deep eutectic system for enhanced treatment of melanoma

Xu, J., Yang, B., Zhu, J., Cui, X., Yang, Y. J., Zhang, W., & Wang, C. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125466 · Cited by 4 · see citing works

Drug Delivery Applications of Peptide Materials

Hamsici, S., Gunay, G., Kirit, H. A., Kamatar, A., Loving, K., & Acar, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839161148-00291 · Cited by 4 · see citing works

Development and evaluation of gluconic acid-targeted liposomal doxorubicin for enhanced anti-tumor activity in colon cancer

Dadpour, S., Mashreghi, M., Shahraki, N., Mehrabian, A., Moosavian, S. A., & Jaafari, M. R. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.104006 · Cited by 3 · see citing works

Targeting tumor glycolysis metabolism in oral squamous cell carcinoma cells by brusatol

Zhang, G., Wu, Y., Chen, S., Su, Y., Yin, P., Fu, J., & Zhang, X. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100172 · Cited by 3 · see citing works

Cibler le métabolisme tumoral : efficacité et perspectives

Hadoux, J., & Massard, C. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2321-7 · Cited by 3 · see citing works

Developing Ligands to Target Transition Metals in Cancer

Utterback, R. D., & Tomat, E. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2694 · Cited by 3 · see citing works

Self-Assembly of Peptides, Peptoids, Sugars, & Dendrimers

Conda‐Sheridan, M. (2023) · ACS in focus · doi:10.1021/acsinfocus.7e7019 · Cited by 2 · see citing works

Progress of research on glucose transporter proteins in hepatocellular carcinoma

Ruan, Z., Wang, Y., Shi, L., & Yang, X. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i3.104715 · Cited by 2 · see citing works

Fluorescent conjugates of D-glucosamine with 3-thiazolylcoumarins: synthesis, characterization and potential use as cell imaging agents

Kuziv, I. B., Novosylna, O. V., & Dubey, I. Y. (2020) · Biopolymers and Cell · doi:10.7124/bc.000a39 · Cited by 2 · see citing works

Low Molecular Weight Modifications of Anthracycline Antibiotics. Part I. Reactions by Amino Group (A Review)

Семаков, А. В. (2024) · Reviews and Advances in Chemistry · doi:10.1134/s2634827624600440 · Cited by 1 · see citing works

The increase in receptor-mediated endocytosis of drugs in the composition of nanoparticles with the address fragment

Kostryukova, L. V., Sanzhakov, M. A., Ignatov, D., Prozorovskyi, V. N., Druzhilovskaya, O. S., Kasatkina, E. S., Medvedeva, N. V., & Ipatova, O. M. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166203306 · Cited by 1 · see citing works

Non-Patentable Chemicals for Cancer Therapy

Ovcharenko, D. (2024) · Advances in Cancer Research & Clinical Imaging · doi:10.33552/acrci.2024.04.000584

Recent Advancements in Prodrug Strategies for Targeted Cancer Therapy

Lee, C. B., Tenora, L., Ranjit, A., Tenorová, K., & Rais, R. (2025) · Progress in drug research · doi:10.1007/978-3-032-00796-4_14

Engineering of Thermoresponsive Diblock Elastin-like Polypeptides

Georgilis, E. (2019) · doi:10.70675/231c8099zcbc9z4449za7d4z866599f0c8d3

Synthèse de prodrogues bispécifiques activables en milieu hypoxique : application au traitement du chondrosarcome et nouvelles perspectives dans le cadre du cancer de la prostate

Gérard, Y. (2018) · theses.fr (ABES) · doi:10.70675/90d554f3z247fz414fzb972z3e282901963f

Mechanism of action of a new organometallic compound inhibitor of topoisomerase I in adenocarcinomas

Molinaro, C. (2023) · theses.fr (ABES) · doi:10.70675/98b43d98zd02bz42a9z89ebz27012480adda

Visible-light-promoted Pd-catalyzed synthesis of β-glycosyl esters from N -hydroxyphthalimide esters and glycosyl bromides

Das, R., Basumatary, J., Roy, B., Mukherjee, D., & Kundu, T. (2026) · Chemical Communications · doi:10.1039/d6cc05273h

[Construction of an adriamycin-glycyrrhizin molecular complex and assessment of its antitumor activity].

Lu, X., Liu, Y. X., Zhu, Y., Zhao, B., Li, W., & Li, G. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.04.20 · Cited by 1 · see citing works

2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity

Mi, Q., Ma, Y., Gao, X., Liu, R., Liu, P., Mi, Y. M., Fu, X., & Gao, Q. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1114972 · Cited by 29 · see citing works

Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.

Aft, R., Lewis, J. S., Zhang, F., Kim, J., & Welch, M. J. (2003) · PubMed · Cited by 56 · see citing works

Sensitivity of multidrug resistant KB-C1 cells to an antibody-dextran-adriamycin conjugate.

Sheldon, K. M., Marks, A., & Baumal, R. (1989) · PubMed · Cited by 16 · see citing works

Exploiting Metabolic Vulnerabilities in Cancer with a Dual-Transporter-Targeted 2-Deoxyglucose Analogue for Low-Dose, Potent Antitumor Activity

Jeon, S., Qin, X., Hildebrand, M. A., Odom, T. L., Zamborini, I., Patel, R., Liu, X., Seo, C., & Callmann, C. E. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c18136 · Cited by 3 · see citing works